Business Description
Ernexa Therapeutics Inc. is a Cambridge, Massachusetts-based company founded in 2018 that creates stem cell-based treatments for cancer and autoimmune diseases. Its two lead treatments target ovarian cancer and rheumatoid arthritis by using specially engineered stem cells that release proteins to either attack tumors or calm an overactive immune system. The company operates under a licensing agreement with Factor Bioscience Limited and was previously known as Eterna Therapeutics Inc. before renaming itself in March 2025.
